OakLabs GmbH is a privately held company founded in 2011 near Berlin, Germany. It collaborates with pharma and diagnostic companies worldwide to develop predictive biomarkers of superior accuracy and thus to boost the success of drugs in clinical trial or on the market.
OakLabs can look back at more than 8 successful years on the market with a proven track record and an ISO 9001 certification which was acquired in 2018. In the same year, a new office in Boston, USA, opened.
OakLabs' team of biologists, chemists, mathematicians, quantum physicists and biostatisticians has extensive real world experience turning drug development projects into success stories.